Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Dec;63(12):1645-8.
doi: 10.1136/ard.2003.015552.

Association of HLA-DM polymorphism with the production of antiphospholipid antibodies

M L Sanchez  1 , K Katsumata, T Atsumi, F I Romero, M L Bertolaccini, A Funke, O Amengual, E Kondeatis, R W Vaughan, A Cox, G R V Hughes, M A Khamashta
Affiliations

Association of HLA-DM polymorphism with the production of antiphospholipid antibodies

M L Sanchez et al. Ann Rheum Dis. 2004 Dec.

Abstract

Objective: To investigate whether variation in the HLA-DM gene is important in producing a group of pathogenic autoantibodies-antiphospholipid antibodies (aPL)-on the basis that HLA class II restricted antigen presentation is involved in the production of aPL.

Methods: HLA-DMA and DMB polymorphisms were genotyped by polymerase chain reaction combined with restriction enzyme digestion in 51 white patients with primary antiphospholipid syndrome (APS), 82 with systemic lupus erythematosus (SLE) (42 with APS and 40 without APS), and 109 healthy white controls. The association with the aPL profile was examined.

Results: The distribution of DMA alleles in APS patients and in patients with APS associated with SLE was significantly different from that in controls by 4x2 chi(2) test with 3 degrees of freedom (p = 0.035 and 0.011, respectively), but it was not different between SLE patients without APS and controls. The allelic distribution of DMA was also different between patients with IgG class anticardiolipin antibody or those with lupus anticoagulant (LA) and controls (p = 0.012 and 0.007, respectively) and between patients with and without LA among SLE patients (p = 0.035). All these differences included the increase in DMA*0102 in the former groups.

Conclusions: The results suggest that HLA-DMA*0102 or its linked gene(s) form one of the genetic risks for the production of aPL.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Thromb Haemost. 1995 Oct;74(4):1185-90 - PubMed
    1. Arthritis Rheum. 1999 Jul;42(7):1309-11 - PubMed
    1. Tissue Antigens. 1996 Jun;47(6):530-7 - PubMed
    1. Hum Immunol. 1996 Aug;49(1):22-7 - PubMed
    1. Lupus. 1996 Aug;5(4):259-62 - PubMed